NEW YORK (Reuters Health) – Both low and high levels of adiponectin are associated with an increased risk of death in patients with type 2 diabetes, according to…
NEW YORK (Reuters Health) – For patients with a hematocrit nadir of 24%-30% following percutaneous coronary intervention (PCI), the benefits of blood transfusion are unlikely to outweigh the…
NEW YORK (Reuters Health) – Elevated levels of high-sensitivity C-reactive protein (hsCRP), an inflammatory marker, predicted mortality and myocardial infarction but not stroke in a multiethnic cohort. “Our…
NEW YORK (Reuters Health) – Neoadjuvant treatment with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor, can help downstage bladder cancer to organ-confined disease, thereby increasing the…
NEW YORK (Reuters Health) – Elevated pre-operative blood levels of brain natriuretic peptide (BNP) or N-terminal-proBNP identify patients who are at increased risk for cardiovascular events within 30…
NEW YORK (Reuters Health) – For now at least, the U.S. Preventive Services Task Force (USPSTF) does not recommend that nontraditional risk factors for coronary heart disease be…
NEW YORK (Reuters Health) – For diagnosing heart failure-related pleural effusions, pleural fluid levels of N-terminal pro-brain natriuretic peptide (NT-pro-BNP) are more accurate than BNP levels, say researchers…
NEW YORK (Reuters Health) – Cephalocaudal jaundice progression does not correlate with bilirubin levels, especially in late-term premature infants, a new prospective study shows. Visual assessment of jaundice…
NEW YORK (Reuters Health) – In most patients with Crohn’s disease, endoscopic findings have relatively little impact on clinical decision making, results of a study conducted in Italy…
NEW YORK (Reuters Health) – Bilirubin screening in all infants could reduce the incidence of severe hyperbilirubinemia, but at the same time increase use of phototherapy at bilirubin…